Kelly Lawrence W & Associates’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2
Closed -$34 164
2024
Q4
$34 Hold
2
﹤0.01% 169
2024
Q3
$45 Hold
2
﹤0.01% 172
2024
Q2
$49 Hold
2
﹤0.01% 178
2024
Q1
$66 Hold
2
﹤0.01% 178
2023
Q4
$73 Hold
2
﹤0.01% 172
2023
Q3
$73 Hold
2
﹤0.01% 164
2023
Q2
$77 Hold
2
﹤0.01% 161
2023
Q1
$82 Hold
2
﹤0.01% 166
2022
Q4
$69 Hold
2
﹤0.01% 165
2022
Q3
$0 Hold
2
﹤0.01% 174
2022
Q2
$0 Buy
+2
New +$67 ﹤0.01% 174

Other funds holding ADNT

Kelly Lawrence W & Associates's ADNT Position: Q1 2025 in Review

Kelly Lawrence W & Associates sold out of Adient (ADNT) in Q1 2025, closing a stake of 2 shares — an estimated $34 sold.

Kelly Lawrence W & Associates first reported a position in ADNT in Q2 2022 and held it in 11 quarters. The position peaked at $82 in Q1 2023. 269 funds tracked by Wall St. Rank hold ADNT as of Q1 2025.

  • Kelly Lawrence W & Associates reported no remaining Adient position as of Q1 2025 after selling out during the quarter.
  • Kelly Lawrence W & Associates sold 2 Adient shares in Q1 2025, an estimated $34.
  • Kelly Lawrence W & Associates first reported a position in Adient in Q2 2022 and held it in 11 quarters.
  • Kelly Lawrence W & Associates's Adient position peaked at $82 in Q1 2023.
  • 269 funds tracked by Wall St. Rank held Adient as of Q1 2025.

Based on Kelly Lawrence W & Associates's 13F filing for Q1 2025, filed 14 May 2025.